Corrigendum to: Mutational analysis of mononucleotide repeats in dual specificity tyrosine phosphatase genes in gastric and colon carcinomas with microsatellite instability: PHOSPHASE MUTATION IN CANCERS (APMIS, (2010), 118, 5, (389-393), 10.1111/j.1600-0463.2010.02612.x);Mutational analysis of mononucleotide repeats in dual specificity tyrosine phosphatase genes in gastric and colon carcinomas with microsatellite instability

APMIS

Volumn 118, Issue 5, 2010, Pages 389-393

  Song, Sang Yong ^a   Kang, Mi Ran ^b   Yoo, Nam Jin ^b   Lee, Sug Hyung ^b  

^a Sungkyunkwan University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Cancer; Dual specificity phosphatase; MSI; Mutation

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE CDC14A; PROTEIN MTM1; PROTEIN MTM3; PROTEIN SSH1; PROTEIN SSH2; TUMOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; ARTICLE; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; FRAMESHIFT MUTATION; GENE DELETION; GENE DUPLICATION; GENE FUNCTION; GENETIC CODE; GENETIC DATABASE; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; MUTATIONAL ANALYSIS; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

EID: 77951094639     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.13126     Document Type: Erratum

References (22)

1. Gschwind A, Fischer OM, Ullrich A. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat Rev Cancer 2004 4 : 361 370. (Pubitemid 38579482)
2. Neel BG, Tonks NK. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol 1997 9 : 193 204.
3. Besco JA, Frostholm A, Popesco MC, Burghes AH, Rotter A. Genomic organization and alternative splicing of the human and mouse RPTPrho genes. BMC Genomics 2001 2 : 1.
4. McAndrew PE, Frostholm A, White RA, Rotter A, Burghes AH. Identification and characterization of RPTP rho, a novel RPTP mu/kappa-like receptor protein tyrosine phosphatase whose expression is restricted to the central nervous system. Brain Res Mol Brain Res 1998 56 : 9 21.
5. Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, Szabo S, et al. Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 2004 304 : 1164 1166.
6. Imai K, Yamamoto H. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 2008 29 : 673 680.
7. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995 268 : 1336 1338.
8. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997 275 : 967 969. (Pubitemid 27087710)
9. Schwartz S Jr., Yamamoto H, Navarro M, Maestro M, Reventós J, Perucho M. Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1999 59 : 2995 3002.
10. Korff S, Woerner SM, Yuan YP, Bork P, von Knebel Doeberitz M, Gebert J. Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with micro-satellite instability. BMC Cancer 2008 8 : 329.
11. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998 58 : 5248 5257.
12. Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, et al. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene 1999 18 : 3754 3760.
13. Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, et al. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 2005 24 : 1477 1480.
14. Camps M, Nichols A, Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 2000 14 : 6 16.
15. Lyon MA, Ducruet AP, Wipf P, Lazo JS. Dual-specificity phosphatases as targets for antineoplastic agents. Nat Rev Drug Discov 2002 1 : 961 76.
16. Pulido R, Hooft van Huijsduijnen R. Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease. FEBS J 2008 275 : 848 866.
17. Shou W, Seol JH, Shevchenko A, Baskerville C, Moazed D, Chen ZW, et al. Exit from mitosis is triggered by Tem1-dependent release of the protein phosphatase Cdc14 from nucleolar RENT complex. Cell 1999 97 : 233 244.
18. Azzam R, Chen SL, Shou W, Mah AS, Alexandru G, Nasmyth K, et al. Phosphorylation by cyclin B-Cdk underlies release of mitotic exit activator Cdc14 from the nucleolus. Science 2004 305 : 516 519.
19. Li L, Ljungman M, Dixon JE. The human Cdc14 phosphatases interact with and dephosphorylate the tumor suppressor protein p53. J Biol Chem 2000 275 : 2410 2414.
20. Paulsen MT, Starks AM, Derheimer FA, Hanasoge S, Li L, Dixon JE, et al. The p53-targeting human phosphatase hCdc14A interacts with the Cdk1/cyclin B complex and is differentially expressed in human cancers. Mol Cancer 2006 5 : 25.
21. Mailand N, Lukas C, Kaiser BK, Jackson PK, Bartek J, Lukas J. Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation. Nat Cell Biol 2002 4 : 317 322.
22. Walker DM, Urbe S, Dove SK, Tenza D, Raposo G, Clague MJ. Characterization of MTMR3, an inositol lipid 3-phosphatase with novel substrate specificity. Curr Biol 2001 11 : 1600 1605.